GC60229
LQZ-7I
Also known as 2-N,3-N-bis(4-fluorophenyl)quinoxaline-2,3-diamine
LQZ-7I is a survivin-targeting inhibitor· LQZ-7I inhibits survivin dimerization· LQZ-7I orally effectively inhibits xenograft tumor growth and induces survivin loss in tumors
ChemicalCAS195822-23-2MW348.35FormulaC20H14F2N4
- CAS number
- 195822-23-2
- Molecular weight
- 348.35
- Formula
- C20H14F2N4
- Solubility
- DMSO： 125 mg/mL (358·83 mM)
- InChIKey
- DKPCKOKYSVPFEB-UHFFFAOYSA-N
- Catalogue number
- GC60229
- Brand
- GLPBIO
Computed properties PubChem CID 468690 · XLogP 5.2 · TPSA 49.8 Ų · H-bond donors 2
- XLogP
- 5.2
- TPSA
- 49.8 Ų
- H-bond donors
- 2
- H-bond acceptors
- 6
- Rotatable bonds
- 4
- Heavy atoms
- 26
SMILES C1=CC=C2C(=C1)N=C(C(=N2)NC3=CC=C(C=C3)F)NC4=CC=C(C=C4)F
Computed descriptors from PubChem (CID 468690), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il